said its pharmaceutical technologies inc subsidiary will market europe its immunol nutritional product designed protect individuals exposed medium minimal radiation dosage levels company said will market product europe because radiation exposure from chernobyl nucelar power accident company asserted product can offset deleterious effects radiation which weakens immune system reuter 